Pharma Journalist -

GlaxoSmithKline plc announced that the US Food and Drug Administration (FDA) has approved JEMPERLI (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody, based on…
Read More...

Claritas Pharmaceuticals, Inc. announced that it has entered into an agreement with CMAX Clinical Research Pty Ltd (“CMAX”) to conduct a randomized, placebo-controlled, single-blind,…
Read More...

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring…
Read More...

A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate…
Read More...

SMi reports: Registration is now open for the Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 22nd and 23rd September.  Established on the…
Read More...

With only a few weeks left to go, the STING & TLR-Targeting Therapies Summit has announced some exciting updates as the industry prepares for this definitive meeting. Over 100…
Read More...

Arriving at a critical point for field, the Non-Small Cell Lung Cancer Drug Development Summit will enable attendees to see a full picture of the clinical trial landscape and identify…
Read More...

ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, and Ossium…
Read More...

PRA Health Sciences announced the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including…
Read More...

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, and OyaGen, Inc. (OyaGen), a pre-clinical biotechnology research company, announced an exclusive…
Read More...